Skip to main content
. Author manuscript; available in PMC: 2021 Feb 21.
Published in final edited form as: Adv Drug Deliv Rev. 2020 Feb 21;153:65–71. doi: 10.1016/j.addr.2020.02.002

Figure 2: Topical treatments of human skin with SIK inhibitors induce pigmentation.

Figure 2:

Skin explants from human breast treated with SIK inhibitor YKL 06–061, YKL 06–062, or HG 9-91-01, demonstrating obvious darkening grossly (A) and after Fontana-Masson staining (B).The figure was adapted from Mujahid N et al., Cell Reports (2017)[34].